These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 18684869)
21. A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting. Dirks J; Haase G; Cantaert T; Frey L; Klaas M; Rickert CH; Girschick H; Meffre E; Morbach H J Clin Immunol; 2022 May; 42(4):771-782. PubMed ID: 35246784 [TBL] [Abstract][Full Text] [Related]
22. AID: how does it aid antibody diversity? Honjo T; Muramatsu M; Fagarasan S Immunity; 2004 Jun; 20(6):659-68. PubMed ID: 15189732 [TBL] [Abstract][Full Text] [Related]
23. APE2 Promotes AID-Dependent Somatic Hypermutation in Primary B Cell Cultures That Is Suppressed by APE1. Schrader CE; Williams T; Pechhold K; Linehan EK; Tsuchimoto D; Nakabeppu Y J Immunol; 2023 Jun; 210(11):1804-1814. PubMed ID: 37074207 [TBL] [Abstract][Full Text] [Related]
24. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation. Durandy A Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279 [TBL] [Abstract][Full Text] [Related]
25. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Lossos IS; Levy R; Alizadeh AA Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936 [TBL] [Abstract][Full Text] [Related]
27. DNA double strand breaks occur independent of AID in hypermutating Ig genes. Bross L; Jacobs H Clin Dev Immunol; 2003; 10(2-4):83-9. PubMed ID: 14768938 [TBL] [Abstract][Full Text] [Related]
28. Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. Kuraoka M; Liao D; Yang K; Allgood SD; Levesque MC; Kelsoe G; Ueda Y J Immunol; 2009 Sep; 183(5):3237-48. PubMed ID: 19667096 [TBL] [Abstract][Full Text] [Related]
29. Activation-induced deaminase: light and dark sides. de Yébenes VG; Ramiro AR Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038 [TBL] [Abstract][Full Text] [Related]
30. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Albesiano E; Messmer BT; Damle RN; Allen SL; Rai KR; Chiorazzi N Blood; 2003 Nov; 102(9):3333-9. PubMed ID: 12855567 [TBL] [Abstract][Full Text] [Related]
31. Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells. Compagno M; Wang Q; Pighi C; Cheong TC; Meng FL; Poggio T; Yeap LS; Karaca E; Blasco RB; Langellotto F; Ambrogio C; Voena C; Wiestner A; Kasar SN; Brown JR; Sun J; Wu CJ; Gostissa M; Alt FW; Chiarle R Nature; 2017 Feb; 542(7642):489-493. PubMed ID: 28199309 [TBL] [Abstract][Full Text] [Related]
32. Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Han JH; Akira S; Calame K; Beutler B; Selsing E; Imanishi-Kari T Immunity; 2007 Jul; 27(1):64-75. PubMed ID: 17658280 [TBL] [Abstract][Full Text] [Related]
33. AID splice variants lack deaminase activity. van Maldegem F; Scheeren FA; Aarti Jibodh R; Bende RJ; Jacobs H; van Noesel CJ Blood; 2009 Feb; 113(8):1862-4; author reply 1864. PubMed ID: 19228934 [No Abstract] [Full Text] [Related]
34. Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID. Kumar Singh A; Tamrakar A; Jaiswal A; Kanayama N; Agarwal A; Tripathi P; Kodgire P Mol Immunol; 2019 Dec; 116():63-72. PubMed ID: 31622795 [TBL] [Abstract][Full Text] [Related]
35. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma. Gu X; Booth CJ; Liu Z; Strout MP Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350 [TBL] [Abstract][Full Text] [Related]
36. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785 [TBL] [Abstract][Full Text] [Related]
37. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139 [TBL] [Abstract][Full Text] [Related]
38. Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Oppezzo P; Dumas G; Lalanne AI; Payelle-Brogard B; Magnac C; Pritsch O; Dighiero G; Vuillier F Blood; 2005 Mar; 105(6):2495-503. PubMed ID: 15561888 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Teng G; Hakimpour P; Landgraf P; Rice A; Tuschl T; Casellas R; Papavasiliou FN Immunity; 2008 May; 28(5):621-9. PubMed ID: 18450484 [TBL] [Abstract][Full Text] [Related]
40. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]